Craft

BioArctic

Stock Price

KR157.9

2024-10-29

Market Capitalization

KR14 B

2024-10-29

Revenue

KR2 B

FY, 2025

BioArctic Summary

Company Summary

Overview
BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. The Company is also focused on the development of treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury.
Type
Public
Status
Active
Founded
2003
HQ
Stockholm , SE | view all locations
Website
https://www.bioarctic.se/en/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Gunilla Osswald
  • Hans Ekelund

    Hans Ekelund, Board Member

    • Gunilla Andersson
    • Oskar Bosson

      Oskar Bosson, Vice President Communications and Investor Relations

    LocationsView all

    1 location detected

    • Stockholm , Stockholms län HQ

      Sweden

      35 Warfvinges väg

    BioArctic Financials

    Summary Financials

    Revenue (FY, 2025)
    kr2.0B
    Gross profit (FY, 2025)
    kr1.9B
    Net income (FY, 2025)
    kr1.0B
    Cash (FY, 2025)
    kr1.0B
    EBIT (FY, 2025)
    kr1.4B
    Enterprise value
    $13.0B

    Footer menu